News

New approach more than doubles stem cell editing efficiency, researchers report

A Penn State-led team of interdisciplinary researchers has developed techniques to improve the efficiency of CRISPR-Cas9, the genome editing technique that earned the Nobel Prize in 2020.

Metabolomics Core Facility continues to expand while pushing scientific bounds

Established nearly a decade ago, Penn State’s Metabolomics Core Facility is housed in the Huck Institutes of the Life Sciences on the University Park campus.

Boy’s discovery reveals highly complex plant-insect interaction

When 8-year-old Hugo Deans discovered a handful of BB-sized objects lying near an ant nest beneath a log in his backyard, he thought they were a type of seed

Penn State team awarded $2.3M to assess disease vulnerability, improve response

An interdisciplinary team from Penn State has been awarded $2.3M from the National Institutes of Health and the National Science Foundation’s joint Ecology and Evolution of Infectious Disease (EEID) program to evaluate the vulnerability of certain populations to disease outbreaks, with the goal of improving outbreak response and preventing future outbreaks.

Boal recieves Early Career Award from Society of Biological Inorganic Chemistry

Amie Boal, professor of chemistry and of biochemistry and molecular biology, has been named a recipient of the 2022 Early Career Award from the International Society for Biological Inorganic Chemistry (SBIC), an organization dedicated to advancing research and promoting understanding of biological inorganic chemistry within academia, industry, and the general public

Cancer, environment event to take place on Sept. 29

The Penn State Cancer Institute and the Institutes of Energy and the Environment (IEE) announced a Cancer and the Environment Symposium from 1–5 p.m. on Thursday, Sept. 29 in the Energy and the Environment Laboratory

Partner-drug resistance accelerates resistance of first-line malaria drug

A new research collaboration between Penn State, Oxford, and Imperial College London demonstrates that resistance to partner drugs facilitates resistance evolution to artemisinin, the world’s most important first-line drug for the treatment of malaria.

Study suggests one-third of wild bee species in Pa. have declined in abundance

Over a six-year period in southcentral Pennsylvania, measures of biodiversity among wild bee communities declined and one-third of species experienced decreases in abundance, according to a Penn State-led team of researchers.

Penn State awarded $1.6M to study if COVID-19 contributes to cognitive decline

As populations around the globe age, dementia — often caused by Alzheimer’s disease and related disorders — is a growing health issue for older adults worldwide.

New granular hydrogel bioink could expand possibilities for tissue bioprinting

Every day in the United States, 17 people die waiting for an organ transplant, and every nine minutes, another person is added to the transplant waiting list, according to the Health Resources and Services Administration.